| Innate and adaptive immune responses against coronavirus A Hosseini, V Hashemi, N Shomali, F Asghari, T Gharibi, M Akbari, ... Biomedicine & pharmacotherapy 132, 110859, 2020 | 159 | 2020 |
| The role of oncomirs in the pathogenesis and treatment of breast cancer M Hemmatzadeh, H Mohammadi, F Jadidi-Niaragh, F Asghari, M Yousefi Biomedicine & Pharmacotherapy 78, 129-139, 2016 | 94 | 2016 |
| Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer F Asghari, N Haghnavaz, B Baradaran, M Hemmatzadeh, T Kazemi Biomedicine & Pharmacotherapy 81, 305-317, 2016 | 41 | 2016 |
| Let-7a could serve as a biomarker for chemo-responsiveness to docetaxel in gastric cancer N Shekari, F Asghari, N Haghnavaz, D Shanehbandi, V Khaze, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 21 | 2019 |
| HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell lines N Haghnavaz, F Asghari, D Elieh Ali Komi, D Shanehbandi, B Baradaran, ... Artificial cells, nanomedicine, and biotechnology 46 (3), 518-523, 2018 | 20 | 2018 |
| Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol. F Asghari, N Haghnavaz, D Shanehbandi, V Khaze, B Baradaran, ... Advances in Clinical & Experimental Medicine 27 (7), 2018 | 18 | 2018 |
| Immunosenescence and Inflammaging in COVID-19 F Asghari, A Asghary, N Majidi Zolbanin, F Faraji, R Jafari Viral Immunology 36 (9), 579-592, 2023 | 4 | 2023 |
| Paclitaxel May Inhibit Epithelial-Mesenchymal Transition Properties of Triple-negative Breast Cancer Cell Line via Altering the Expression of EMT-promoting and–inhibiting MicroRNAs N Haghnavaz, F Asghari, N Shekari, D Shanehbandi, M Javadian, ... Middle East Journal of Cancer 11 (1), 42-49, 2020 | 3 | 2020 |
| Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response A Mihanfar, F Asghari, M Majidinia Molecular Biology Reports 51 (1), 474, 2024 | 1 | 2024 |
| mTORC1 inhibition may improve T lymphocytes affected by aging AAP F Asghari, MH Karimi immunopharmacology and immunotoxicology, 2023 | | 2023 |
| Alterations in the Expression Level of mir-1246 and mir-224 in Breast Cancer Cell Lines After Treatment with Taxol Chemotherapeutic Agent N Haghnavaz, F Asghari, Z Sattari, M Babaei, T Kazemi Journal of Ardabil University of Medical Sciences 18 (4), 479-487, 2019 | | 2019 |
| PR137 CONTRADICTORIES IN VITAMIN D SUPPLEMENTATION ON GENE EXPRESSION OF MICRORNAS INVOLVING IN BREAST CARCINOGENESIS SE Koujan, F Asghari, A Mihanfar The Breast, S69, 2015 | | 2015 |
